← Leaderboards
Guisheng Song
University Of Minnesota
$3,746,703
Attributed
$3,746,703
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $547.6K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,746,703 · 3
By mechanism
R01$3,552,953 · 2
R56$193,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- David R Boulware$24,302,588
- Steve Davidson$4,103,581
Others in their field
Top investigators on “Hepatocyte”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Mark A Kay · Stanford University$31,244,013
- Charles M. Rice · Rockefeller University$27,314,965
- Stephen Lev Hoffman · Sanaria, Inc.$26,407,941
- Stefan H.i. Kappe · Seattle Children'S Hospital$25,211,763
- Michael H Nathanson · Yale University$22,903,080
Research focus
HepatocyteDesignPreventNew Therapeutic TargetLiverHepaticKnock-DownObesityInsightMicrornasMouse ModelCellsMediatingPrimary Carcinoma Of The Liver CellsExperimental DesignsSerumCrispr/Cas TechnologyBaseAutomobile DrivingNon-Insulin-Dependent Diabetes MellitusLipidsDietGenetic TranscriptionFatty Liver
Grant awards (10)
MicroRNA-15a/16-mediated cytokine/chemokine reprogramming in Kupffer cells prevents the development of hepatocellular carcinoma$372,485
R01 · FY2025 · CA · contact PI
MicroRNA-15a/16-mediated cytokine/chemokine reprogramming in Kupffer cells prevents the development of hepatocellular carcinoma$353,861
R01 · FY2024 · CA · contact PI
Role of YY1 in promoting hepatic insulin resistance, hyperglycemia and NAFLD$193,750
R56 · FY2024 · DK · contact PI
MicroRNA-15a/16-mediated cytokine/chemokine reprogramming in Kupffer cells prevents the development of hepatocellular carcinoma$365,037
R01 · FY2023 · CA · contact PI
MicroRNA-15a/16-mediated cytokine/chemokine reprogramming in Kupffer cells prevents the development of hepatocellular carcinoma$372,485
R01 · FY2022 · CA · contact PI
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH$413,641
R01 · FY2018 · DK · contact PI
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH$413,641
R01 · FY2017 · DK · contact PI
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH$413,641
R01 · FY2016 · DK · contact PI
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH$413,641
R01 · FY2015 · DK · contact PI
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH$434,521
R01 · FY2014 · DK · contact PI